GOED and UNPA to host a webinar about mitigating intentional adulteration under FSMA
GOED, in conjunction with its sister organization UNPA, will be hosting a webinar about FDA’s draft guidance on mitigation strategies to protect food against intentional adulteration, a part of the Food Safety and Modernization Act.
Photo © Shutterstock.com/AlexLMX
The Global Organization for EPA and DHA Omega-3s (GOED), in conjunction with its sister organization United Natural Products Alliance (UNPA), will be hosting a webinar about FDA’s draft guidance on mitigation strategies to protect food against intentional adulteration, a part of the Food Safety and Modernization Act (FSMA).
As a result of this guidance, all food facilities, foreign and domestic, are required to register with the FDA under Food Facility Registration and must establish, and implement a written Food Defense Plan. The Key Activity Types that FDA determined are significantly vulnerable are companies engaged in bulk liquid receiving and loading, liquid storage and handling, and secondary ingredient handling such as raw material dispensing, blending operations, and the process of creating pre-blends.
The webinar, taking place on June 12 9:00 PDT/10:00 MDT/11:00 CDT/12:00 EDT, will be presented by Larisa Pavlick, former investigator with the FDA and current VP, global regulatory and compliance at UNPA. GOED and UNPA are offering the webinar for free to its Leadership, Plus, and Executive Level members, and charging $99 to all other members, and $199 to non-members. To participate, register here.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
